Single crystals of ␥-Cu 2 V 2 O 7 were obtained by the method of chemical transport reactions. The crystal structure [triclinic, P1, a 5.0873(10), b 5.8233(11), c 9.4020(18) Å, ␣ 99.780(3),  97.253(3), ␥ 97.202(3)°, V 269.20(9) Å 3 , Z = 2] has been solved by direct methods and refined to R 1 = 0.021 (wR 2 = 0.049) using 949 unique observed reflections with |F o | ≥ 4 F . The atomic arrangement contains two symmetrically independent Cu 2+ cations. The Cu(1) site is coordinated by six O atoms to form a distorted Cu(1)O 6 octahedron, whereas the Cu (2) site is coordinated by five O atoms arranged at the vertices of an elongate Cu(2)O 5 square pyramid. Two symmetrically independent V 5+ cations are tetrahedrally coordinated by four O atoms each. The O(5) atom bridges the V(1)O 4 and V(2)O 4 tetrahedra. The Cu(1)O 6 octahedra and Cu(2)O 5 square pyramids form two types of chains running parallel to the a axis. The chains are linked by V 2 O 7 groups into a complex heteropolyhedral framework. The structure of ␥-Cu 2 V 2 O 7 is closely related to the structures of ␣-Cu 2 V 2 O 7 (blossite) and -Cu 2 V 2 O 7 (ziesite). The three structures are based upon chains of edge-sharing Cu 2+ polyhedra linked by V 2 O 7 groups. Similarity of the structure of ␥-Cu 2 V 2 O 7 to the structures of blossite and ziesite indicates possible formation of this phase under natural conditions, such as those that occur in "dry" high-temperature fumaroles of the Izalco (El Salvador) and Tolbachik (Kamchatka, Russia) volcanoes. The structure of ␥-Cu 2 V 2 O 7 can also be considered as a triclinically distorted derivative of the -A 2 P 2 O 7 structure-type.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.